Big compounders will have until May 22 to stop producing and dispensing compounded semaglutide, while smaller, state-run ...

Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final resolution.

Harvard Medical School experts reported that a rapid loss of fat in the face can cause a hollowed look to the face; changes ...

However, patients who didn't take semaglutide beforehand quickly caught up and had no difference in combined ... have found ...

Popular medications for obesity and diabetes have been linked to an increased risk of hair loss, particularly for women. Researchers and doctors weigh in.

“We have heard this anecdotally when patients consult us for surgical restoration of their face after rapid ... he noted — “and semaglutide-driven loss is likely no exception.” ...

Previous studies have found that taking semaglutide after ... before surgery plateaued at the same percent lost at the six-, nine-, and 12-month marks. The researchers also found that the number and ...

Neoadjuvant semaglutide showed no benefit in weight loss ... similar median HbA1c levels as controls before surgery (5.8% vs. 6%) and 1 year after surgery (5.5% vs. 5.7%). They also observed ...

Hims & Hers has risen 70% since November 2024, outperforming the S&P 500, despite recent regulatory challenges impacting its compounded semaglutide ... before earnings of $2.08 billion. After ...